Overview

PiB PET Scanning in Speech and Language Based Dementias

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The study is designed to determine whether there are clinical features that can be used as biomarkers to predict whether underlying Alzheimer's pathology is the cause of a speech and language based dementia. The primary hypothesis is that the proportion of patients who test positive for beta-amyloid deposition will vary across different speech and language based dementias.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Fluorodeoxyglucose F18